Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia

Luby ED, Ccohen BD, Rosenbaum F, Gottlieb J, Kelley R . Study of a new schizophrenomimetic drug, Sernyl Arch Neurol Psychiatry 1959 81: 363–369

Javitt DC, Zukin SR . Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 1991 148: 1301–1308

Ellison G . The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias Brain Res Brain Res Rev 1995 20: 250–267

Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics Neuropsychopharmacology 1997 17: 141–150

Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH . The NMDA antagonist model for schizophrenia: promise and pitfalls Pharmacopsychiatry 1998 31 Suppl 2: 104–109

Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D et al. Glutamate receptors: brain function and signal transduction Brain Res Brain Res Rev 1998 26: 230–235

Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K et al. Molecular diversity of the NMDA receptor channel Nature 1992 358: 36–41

Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes Science 1992 256: 1217–1221

Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M et al. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death Neuron 1994 13: 325–338

Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S . Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice Cell 1994 76: 427–437

Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S, Mishina M . Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel Brain Res Mol Brain Res 1995 33: 61–71

Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit Nature 1995 373: 151–155

Ebralidze AK, Rossi DJ, Tonegawa S, Slater NT . Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene J Neurosci 1996 16: 5014–5025

Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E et al. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice Neuron 1996 16: 333–344

Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A Nature 1998 393: 377–381

Mohn AR, Gainetdinov RR, Caron MG, Koller BH . Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 1999 98: 427–436

Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K et al. Molecular diversity of the NMDA receptor channel Nature 1992 358: 36–41

Watanabe M, Inoue Y, Sakimura K, Mishina M . Developmental changes in distribution of NMDA receptor channel subunit mRNAs Neuroreport 1992 3: 1138–1140

Standaert DG, Testa CM, Young AB, Penney JB, Jr . Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat J Comp Neurol 1994 343: 1–16

Kayadjanian N, Heavens RP, Besson MJ, Sirinathsinghji DJ . Striatal NMDAR2B mRNA expression after bilateral cortical and unilateral nigral deafferentation Neuroreport 1996 7: 713–716

Rudolf GD, Cronin CA, Landwehrmeyer GB, Standaert DG, Penney JB, Jr, Young AB . Expression of N-methyl-D-aspartate glutamate receptor subunits in the prefrontal cortex of the rat Neuroscience 1996 73: 417–427

Toyoda H, Takahata R, Inayama Y, Sakai J, Matsumura H, Yoneda H et al. Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats Neurochem Res 1997 22: 249–252

Chen AC, McDonald B, Moss SJ, Gurling HM . Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis- and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment Brain Res Mol Brain Res 1998 54: 92–100

Oretti RG, Spurlock G, Buckland PR, McGuffin P . Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains Neurosci Lett 1994 177: 39–43

Riva MA, Tascedda F, Lovati E, Racagni G . Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs Brain Res Mol Brain Res 1997 50: 136–142

Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA et al. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs Hum Mol Genet 1999 8: 1729–1739

Dawson E, Powell JF, Sham P, Shaikh S, Taylor C, Clements A et al. Systematic search for major genes in schizophrenia: methodological issues and results from chromosome 12 Am J Med Genet 1995 60: 424–433

Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J et al. A genomewide search for schizophrenia susceptibility genes Am J Med Genet 1998 81: 364–376

Riley BP, Tahir E, Rajagopalan S, Mogudi-Carter M, Faure S, Weissenbach J et al. A linkage study of the N-methyl-D-aspartate receptor subunit gene loci and schizophrenia in southern African Bantu-speaking families Psychiatr Genet 1997 7: 57–74

Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium Am J Med Genet 1998 81: 290–295

Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311 Cys and DRD3 Ser9Gly polymorphisms Am J Med Genet 1998 81: 24–28